Cargando…

Simultaneous hybrid revascularization for symptomatic lower extremity arterial occlusive disease

Multilevel revascularization, using a combination of endovascular and open (hybrid) surgery, is increasingly being used. Hybrid surgery allows complex anatomy to be treated by minimally invasive procedures in medically high risk patients. The aim of the present study was to report a novel hybrid sur...

Descripción completa

Detalles Bibliográficos
Autores principales: JOH, JIN HYUN, JOO, SUN-HYUNG, PARK, HO-CHUL
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961109/
https://www.ncbi.nlm.nih.gov/pubmed/24669236
http://dx.doi.org/10.3892/etm.2014.1513
_version_ 1782308229865275392
author JOH, JIN HYUN
JOO, SUN-HYUNG
PARK, HO-CHUL
author_facet JOH, JIN HYUN
JOO, SUN-HYUNG
PARK, HO-CHUL
author_sort JOH, JIN HYUN
collection PubMed
description Multilevel revascularization, using a combination of endovascular and open (hybrid) surgery, is increasingly being used. Hybrid surgery allows complex anatomy to be treated by minimally invasive procedures in medically high risk patients. The aim of the present study was to report a novel hybrid surgery for lesions in the multilevel lower extremity arteries and to evaluate the clinical outcomes. Consecutive patients who presented at a single institution between March 2009 and Feburary 2012 were selected for inclusion in the study. The patients had disabling claudication or critical limb ischemia and underwent treatment for revascularization by open surgery or by a combination of open surgery and endovascular procedure. Retrospective analysis was conducted from a prospectively collected database. All procedures were performed by a vascular surgeon in an operating room. Postoperative surveillance in outpatient clinics was conducted at 3 and 6 months and every 6 months thereafter. A total of 76 patients were included in the study with a mean age of 67.1±11.3 years (range, 42–94 years) and the male to female ratio was 67:9. The most common indication for revascularization was Rutherford category IV (resting pain). The immediate technical success rate of hybrid surgery was 90.5%, with an overall limb salvage rate of 97.4%. The primary patency rates of the hybrid and open groups were 100 and 90.9%, respectively (P=0.441). Therefore, the results of the present study indicate that hybrid surgery is a feasible option for the treatment of multilevel peripheral arterial occlusive disease, showing favorable patency and limb salvage rates. These observations indicate that femoral endarterectomy plays a vital role in hybrid surgery.
format Online
Article
Text
id pubmed-3961109
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-39611092014-03-25 Simultaneous hybrid revascularization for symptomatic lower extremity arterial occlusive disease JOH, JIN HYUN JOO, SUN-HYUNG PARK, HO-CHUL Exp Ther Med Articles Multilevel revascularization, using a combination of endovascular and open (hybrid) surgery, is increasingly being used. Hybrid surgery allows complex anatomy to be treated by minimally invasive procedures in medically high risk patients. The aim of the present study was to report a novel hybrid surgery for lesions in the multilevel lower extremity arteries and to evaluate the clinical outcomes. Consecutive patients who presented at a single institution between March 2009 and Feburary 2012 were selected for inclusion in the study. The patients had disabling claudication or critical limb ischemia and underwent treatment for revascularization by open surgery or by a combination of open surgery and endovascular procedure. Retrospective analysis was conducted from a prospectively collected database. All procedures were performed by a vascular surgeon in an operating room. Postoperative surveillance in outpatient clinics was conducted at 3 and 6 months and every 6 months thereafter. A total of 76 patients were included in the study with a mean age of 67.1±11.3 years (range, 42–94 years) and the male to female ratio was 67:9. The most common indication for revascularization was Rutherford category IV (resting pain). The immediate technical success rate of hybrid surgery was 90.5%, with an overall limb salvage rate of 97.4%. The primary patency rates of the hybrid and open groups were 100 and 90.9%, respectively (P=0.441). Therefore, the results of the present study indicate that hybrid surgery is a feasible option for the treatment of multilevel peripheral arterial occlusive disease, showing favorable patency and limb salvage rates. These observations indicate that femoral endarterectomy plays a vital role in hybrid surgery. D.A. Spandidos 2014-04 2013-08-17 /pmc/articles/PMC3961109/ /pubmed/24669236 http://dx.doi.org/10.3892/etm.2014.1513 Text en Copyright © 2014, Spandidos Publications http://creativecommons.org/licenses/by/3.0 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Articles
JOH, JIN HYUN
JOO, SUN-HYUNG
PARK, HO-CHUL
Simultaneous hybrid revascularization for symptomatic lower extremity arterial occlusive disease
title Simultaneous hybrid revascularization for symptomatic lower extremity arterial occlusive disease
title_full Simultaneous hybrid revascularization for symptomatic lower extremity arterial occlusive disease
title_fullStr Simultaneous hybrid revascularization for symptomatic lower extremity arterial occlusive disease
title_full_unstemmed Simultaneous hybrid revascularization for symptomatic lower extremity arterial occlusive disease
title_short Simultaneous hybrid revascularization for symptomatic lower extremity arterial occlusive disease
title_sort simultaneous hybrid revascularization for symptomatic lower extremity arterial occlusive disease
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961109/
https://www.ncbi.nlm.nih.gov/pubmed/24669236
http://dx.doi.org/10.3892/etm.2014.1513
work_keys_str_mv AT johjinhyun simultaneoushybridrevascularizationforsymptomaticlowerextremityarterialocclusivedisease
AT joosunhyung simultaneoushybridrevascularizationforsymptomaticlowerextremityarterialocclusivedisease
AT parkhochul simultaneoushybridrevascularizationforsymptomaticlowerextremityarterialocclusivedisease